BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

Clovis Oncology 

1871 Folsom Street

Boulder  Colorado  80302  U.S.A.
Phone: n/a Fax: n/a


SEARCH JOBS










 Company News
Tiny Clovis Oncology (CLVS) Races With AstraZeneca PLC (AZN) To Develop Lung Cancer Drug 10/2/2014 6:11:31 AM
Clovis Oncology (CLVS) Release: Data From Ongoing Phase 2 Studies Of Rucaparib In Ovarian Cancer Demonstrate Safety And Clinical Activity, Validate Differentiated Strategy 9/29/2014 2:11:24 PM
Clovis Oncology (CLVS) Announces First Patient Enrolled in Lucitanib Phase 2 Study In FGF-aberrant Advanced Breast Cancer 9/11/2014 11:17:08 AM
Clovis Oncology (CLVS) Announces Exercise In Full By Initial Purchasers Of Their Option To Purchase An Additional $37.5 Million Aggregate Principal Amount Of The Company’s 2.50% Convertible Senior Notes Due 2021 9/9/2014 10:36:55 AM
Clovis Oncology (CLVS) To Present At The 2014 Morgan Stanley Global Healthcare Conference 9/8/2014 10:00:20 AM
Clovis Oncology (CLVS) Announces Pricing Of $250 Million Of Convertible Senior Notes 9/4/2014 12:36:52 PM
Clovis Oncology (CLVS) To Offer $200 Million Of Convertible Senior Notes 9/3/2014 1:49:54 PM
Clovis Oncology (CLVS) Announces Second Quarter 2014 Operating Results 8/8/2014 9:06:05 AM
Clovis Oncology (CLVS) To Announce Second Quarter 2014 Financial Results And Host Webcast Conference Call On August 7 7/22/2014 12:21:41 PM
Clovis Oncology (CLVS) Announces First Patient Enrolled In TIGER2 Study 6/23/2014 12:19:44 PM
123456789